| 回到 StockQ 正常版首頁 |
|
| 技術線圖 |
| 5日平均 | 10日平均 | 20日平均 |
| 8611.40 | 8548.27 | 8678.03 |
| 60日平均 | 120日平均 | 260日平均 |
| 9173.98 | 9005.85 | 8440.30 |
| Date | Price | Change% |
| 2026/08/07 | 8855.04 | 1.83% |
| 2026/08/06 | 8696.33 | -0.12% |
| 2026/08/05 | 8707.203 | 2.32% |
| 2026/08/04 | 8510.128 | 2.68% |
| 2026/08/03 | 8288.278 | -1.48% |
| 2026/07/31 | 8412.471 | 2.04% |
| 2026/07/30 | 8243.971 | -3.01% |
| 2026/07/29 | 8499.523 | 0.30% |
| 2026/07/28 | 8474.179 | -3.65% |
| 2026/07/27 | 8795.543 | 2.79% |
| 2026/07/24 | 8556.822 | -1.81% |
| 2026/07/23 | 8714.917 | 0.37% |
| 2026/07/22 | 8682.679 | -0.85% |
| 2026/07/21 | 8756.804 | 3.83% |
| 2026/07/20 | 8434.18 | -1.98% |
| 2026/07/17 | 8604.665 | -4.88% |
| 2026/07/16 | 9045.83 | -0.98% |
| 2026/07/15 | 9135.391 | -0.63% |
| 2026/07/14 | 9193.378 | 2.68% |
| 2026/07/13 | 8953.187 | -3.51% |
| 名稱 | 三個月 | 六個月 | 一年 | 今年 |
| 中小板指指數 | 10.10% | 5.58% | 23.44% | 3.66% |
| 聯博中國優化波動股票基金-A股/美元 | 4.47% | -3.17% | -12.52% | 2.34% |
| 聯博中國優化波動股票基金-A股/歐元 | 2.85% | -5.25% | -15.61% | 3.30% |
| 聯博中國A股基金-A2類型/台幣 | 1.86% | 7.35% | 36.45% | 10.58% |
| 聯博中國A股基金-A2類型/美元 | -0.54% | 5.45% | 26.91% | 7.79% |
| 聯博中國A股基金-A2類型/人民幣 | -1.42% | 2.59% | 19.06% | 4.13% |
| 富達中國聚焦基金/美元 | -5.98% | -10.67% | -1.88% | -7.50% |
| 法巴中國股票基金-C股/美元 | 18.77% | 22.80% | 31.79% | 18.92% |
| 安聯中國策略基金/台幣 | 5.93% | 18.24% | 62.12% | 22.21% |
| 安聯中國股票基金-A股/配息/美元 | -2.50% | -2.33% | 4.93% | -0.37% |
| 霸菱香港中國基金-A類/配息/歐元 | -6.27% | -4.14% | 5.22% | -0.88% |
| 霸菱香港中國基金-A類/配息/美元 | -8.24% | -6.16% | 4.63% | -2.62% |
| 霸菱香港中國基金-A類/配息/英鎊 | -7.06% | -5.31% | 3.51% | -2.67% |
| 貝萊德中國基金A2/美元 | -6.09% | -1.77% | 4.06% | -0.19% |
| 貝萊德中國基金A2-歐元避險 | -6.67% | -3.00% | 1.53% | -1.69% |
| 貝萊德中國基金A2-澳幣避險 | -6.25% | -2.06% | 3.08% | -0.74% |
| 群益華夏盛世基金/台幣 | 4.91% | 22.40% | 55.53% | 27.58% |
| 群益華夏盛世基金/美元 | 2.44% | 20.22% | 44.61% | 24.35% |
| 群益華夏盛世基金/人民幣 | 1.47% | 16.98% | 35.73% | 20.09% |
| 群益中國新機會基金/台幣 | -1.88% | 27.60% | 54.35% | 31.31% |
| 群益中國新機會基金/美元 | -4.20% | 25.27% | 43.40% | 28.00% |
| 群益中國新機會基金/人民幣 | -5.10% | 21.90% | 34.59% | 23.61% |
| DWS投資中國股票基金E2/美元 | 3.65% | 17.91% | 23.93% | 15.77% |
| DWS投資中國股票基金A2/美元 | 14.96% | 19.61% | 24.27% | 15.09% |
| DWS投資中國股票基金FC/歐元 | -2.39% | 3.13% | 13.75% | 2.31% |
| DWS投資中國股票基金LC/歐元 | 8.52% | 5.45% | 15.14% | 2.42% |
| 瀚亞中國基金/台幣 | -3.29% | -11.79% | 15.16% | -9.18% |
| 瀚亞中國股票基金/美元 | -2.95% | -6.39% | 3.39% | -5.66% |
| 愛德蒙得洛希爾中國基金(A)/歐元 | -1.76% | 3.10% | 23.33% | 2.06% |
| 愛德蒙得洛希爾中國基金(A)/美元 | 3.84% | 17.76% | 34.15% | 15.82% |
| 歐義銳榮中國股票基金-R/歐元 | 0.00% | -4.06% | 0.35% | -2.59% |
| 歐義銳榮中國股票基金-R2/美元 | -1.30% | -6.02% | 0.24% | -4.18% |
| 首域盈信中國核心基金/美元 | 9.16% | 12.40% | 18.57% | 6.94% |
| 富蘭克林華美中國消費基金/台幣 | -1.74% | 4.57% | 25.95% | 7.50% |
| 富蘭克林華美中國傘型基金之中國A股基金/台幣 | 2.71% | 14.75% | 39.55% | 17.85% |
| 富蘭克林華美中國傘型基金之中國A股基金/人民幣 | -0.81% | 9.58% | 21.78% | 10.94% |
| 富蘭克林華美中國傘型基金之中國A股基金/美元 | 0.17% | 12.55% | 29.57% | 14.69% |
| 復華華人世紀基金/台幣 | -1.90% | 44.04% | 115.95% | 63.04% |
| 復華大中華中小策略基金/台幣 | -0.81% | 67.04% | 136.84% | 79.25% |
| 匯豐中國動力基金-台幣 | -3.74% | 5.91% | 44.09% | 14.52% |
| 匯豐中國股票基金AD/美元 | 13.70% | 18.83% | 17.02% | 13.93% |
| 景順中國基金-A股/美元 | -5.01% | -8.66% | 1.55% | -5.01% |
| 景順中國基金-A股/歐元對沖 | -5.51% | -9.75% | -0.95% | -6.36% |
| 景順中國基金-A股/澳幣對沖 | -5.04% | -8.85% | 0.62% | -5.41% |
| 摩根中國基金-A股/分派/美元 | -1.74% | -1.67% | 6.89% | -1.35% |
| 木星中國基金-ACC/美元 | -7.75% | -3.82% | -6.93% | -12.97% |
| 木星中國基金–ACC/英鎊 | 13.43% | 16.64% | 37.41% | 13.75% |
| 野村中國機會基金/台幣 | 9.32% | 28.39% | 53.90% | 31.52% |
| 鋒裕匯理-中國股票基金-A2/美元 | 4.07% | 17.28% | 24.44% | 15.57% |
| 鋒裕匯理-中國股票基金-B2/美元 | 3.90% | 16.86% | 23.56% | 15.21% |
| 鋒裕匯理-中國股票基金-A2/歐元 | -1.77% | 2.48% | 14.18% | 1.67% |
| 荷寶中國股票基金-D/歐元 | -10.74% | -12.16% | -24.25% | -23.76% |
| 荷寶中國股票基金-D/美元 | -5.71% | -10.92% | -21.01% | -20.63% |
| 新光中國成長基金/台幣 | 9.38% | 25.75% | 18.20% | 17.32% |
| 瑞銀(盧森堡)中國精選股票基金/美元 | -7.25% | -9.41% | -5.11% | -7.99% |
| 瑞銀(盧森堡)中國精選股票基金-月配息/美元 | -7.71% | -10.31% | -6.97% | -9.05% |
| 元大新中國基金/台幣 | 1.88% | 14.40% | 44.04% | 17.90% |
| ( 中國基金 ) | 0.00% | 7.53% | 21.50% | 8.72% |
| ||||||||||||
|
StockQ 全球股市指數 © All rights reserved.
|